Edition:
India

Denali Therapeutics Inc (DNLI.OQ)

DNLI.OQ on NASDAQ Stock Exchange Global Select Market

18.70USD
25 Apr 2018
Change (% chg)

$-0.50 (-2.60%)
Prev Close
$19.20
Open
$19.13
Day's High
$19.13
Day's Low
$18.66
Volume
10,906
Avg. Vol
95,120
52-wk High
$25.50
52-wk Low
$14.80

Select another date:

Mon, Mar 19 2018

BRIEF-Denali Therapeutics Reports Qtrly Net Loss Per Share $0.74

* DENALI THERAPEUTICS ANNOUNCES FIRST-IN-HUMAN DOSING OF ITS RIPK1 INHIBITOR CLINICAL PROGRAM AND THE APPOINTMENT OF PETER KLEIN TO BOARD OF DIRECTORS; REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

BRIEF-Temasek Holdings Dissolves Share Stake In Marin Software, Takes Share Stake In Denali Therapeutics

* TEMASEK HOLDINGS (PRIVATE) LTD DISSOLVES SHARE STAKE IN MARIN SOFTWARE INC - SEC FILING

BRIEF-Denali Therapeutics, Lonza Pharma & Biotech Announce Exclusive Partnership To Develop And Produce Biologic Medicines

* DENALI THERAPEUTICS AND LONZA PHARMA & BIOTECH ANNOUNCE EXCLUSIVE PARTNERSHIP TO DEVELOP AND PRODUCE BIOLOGIC MEDICINES

BRIEF-Takeda And Denali Therapeutics Collaborate To Develop Therapies For Neurodegenerative Diseases

* TAKEDA AND DENALI THERAPEUTICS COLLABORATE TO DEVELOP AND COMMERCIALIZE THERAPIES FOR NEURODEGENERATIVE DISEASES

BRIEF-Denali Therapeutics Now Sees IPO Of 13.9 Million Shares Priced Between $17-$19 Per Share

* DENALI THERAPEUTICS INC SEES IPO OF 13.9 MILLION SHARES OF ITS COMMON STOCK PRICED BETWEEN $17.00 AND $19.00 PER SHARE - SEC FILING

Select another date: